###
中国临床研究:2023,36(5):741-745
本文二维码信息
码上扫一扫!
脓毒症免疫抑制机制的研究进展
(中国医科大学附属盛京医院急诊科,辽宁 沈阳 110004)
Research progress in immunosuppressive mechanism of sepsis
(Department of Emergency, Shengjing Hospital Affiliated of China Medical University, Shenyang, Liaoning 110004, China)
摘要
本文已被:浏览 380次   下载 1619
投稿时间:2022-08-13   网络发布日期:2023-05-20
中文摘要: 脓毒症发病机制复杂,早期伴随促炎—抗炎机制的出现,会导致过度炎症和免疫抑制,甚至出现长期的免疫紊乱。随着对脓毒症研究的深入,越来越多的证据表明,免疫抑制是脓毒症的重要特征。虽然脓毒症患者免疫抑制的证据越来越多,但脓毒症是如何影响机体免疫功能,以及脓毒症的免疫抑制对免疫细胞影响的研究还处于初级阶段。本篇综述将聚焦近年来对脓毒症发病机制的研究,为其临床防治提供理论依据。
Abstract:The pathogenesis of sepsis is complex. The early stage of sepsis is accompanied by the emergence of pro-inflammatory-anti-inflammatory mechanisms, which can lead to excessive inflammation and immunosuppression, and even long-term immune disorders. With the in-depth study of sepsis, more and more evidence show that immunosuppression is an important feature of sepsis. Although evidence of immunosuppression in patients with sepsis is increasing, the research on how sepsis affects the body‘s immune function and the effects of sepsis‘s immunosuppression on immune cells is still in its infancy. This review focuses on the recent research on the pathogenesis of sepsis and provides a theoretical basis for its clinical prevention and treatment.
文章编号:     中图分类号:R459.7    文献标志码:A
基金项目:辽宁省教育厅科学研究经费项目(JC2019015);辽宁省民生科技计划联合计划项目(2021JH2/10300107)
引用文本:
付绪哲,柳英杰,牛明明,陈祺润,王煜.脓毒症免疫抑制机制的研究进展[J].中国临床研究,2023,36(5):741-745.

用微信扫一扫

用微信扫一扫